For Immediate Release January 12, 2011 (Toronto) Seven scientists at Canada's Centre for Addiction and Mental Health (CAMH) have been awarded Young Investigator grant awards by the U.S.-based NARSAD: The Brain and Behavior Research Fund.
The CAMH awards will fund genetic, clinical and neuroimaging studies that will ultimately guide future treatments and personalized approaches for people with schizophrenia and depression.
The 124-member NARSAD Scientific Council, a volunteer group of pre-eminent mental health researchers, leads the rigorous and competitive process of identifying the most promising ideas for NARSAD grant awards each year. NARSAD aims to alleviate the suffering of mental illness by awarding grants that will lead to breakthroughs in scientific research. Each award is worth up to $60,000 over two years.
"This body of research represents the cutting-edge of brain and behavior research," said Benita Shobe, NARSAD president and CEO. "Young Investigators are selected for their innovation and potential to improve the lives of people living with mental illness through enhanced treatments and therapies and a better understanding of the causes of mental illness."
"We are thrilled that our researchers have received these awards, which are known to be important in establishing the careers of young scientists," says Dr. Bruce Pollock, Vice-President of Research at CAMH.
Awards were granted for the following CAMH projects:
Dr. Daniel Blumberger will look at specific brain function deficits and treatment resistance in older adults with depression. His study will explore whether these deficits, which occur with aging, predict their response to treatment. These findings will ultimately lead to more effective treatments.
Dr. George Foussias will be using functional magnetic resonance imaging to measure brain activity in people with schizophrenia while they do everyday tasks in a virtual realit
|Contact: Michael Torres|
Centre for Addiction and Mental Health